Latest Post

September 02, 2020

SARS-CoV-2 Vaccines – Alternative Vial Components

The need to provide vaccines for the SARS-CoV-2 pandemic has presented the pharmaceutical industry with unprecedented challenges. Among them are accelerated timelines for development/approval and unanticipated volumes for manufacture/delivery. Ordinarily for a new drug product, there is ample time for selecting the primary package system and establishing component availability.
Whitney Winters

Whitney Winters

Sr. Director, Strategic Marketing, Containment Systems

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Blue West logo with Diamond

    December 15, 2014

    Managing Residual Moisture In Lyophilized Drugs

    West Pharma

    Lynn Yao

    Senior Scientific Affairs Specialist

    Blue West logo with Diamond

    January 06, 2014

    Container Closure Integrity: What does it mean?

    West Pharma

    Kristine Davidson

    Senior Category Specialist, Procurement

    CCI  labs  USP 
    Blue West logo with Diamond

    October 25, 2013

    Paul Cummings to Present at AAPS

    West Pharma

    Analytical Services

    Load more